Fibromat’s options for continued growth

Focus on talent: Ng believes that investing in developing talent will lead to the company’s growth.

TO bring the company to the next level of growth, bioengineering solutions provider Fibromat (M) Bhd is keeping its options open.

Its managing director and chief executive officer Danny Ng shares that he is considering several options as part of the company’s future plans. This includes the possibility for potential mergers and acquisitions, or even seeking alternative financing either locally or internationally.